48-hour Ambulatory EEG Monitoring in Early Onset Alzheimer's Disease

Early Onset Alzheimer Disease Clinical Trial

Official title:
A Prospective Study Evaluating the Use of 48-hour Ambulatory EEG Monitoring in Early Onset Alzheimer's Disease

Status Recruiting

Clinical Trial Summary

Researchers are trying to determine the frequency of seizures and epilepsy in patients with Early-onset Alzheimer's disease (EOAD) using a 48-hour computer assisted ambulatory electroencephalogram.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04002583
Study type	Interventional
Source	Mayo Clinic
Contact	Sabrina Bunn
Phone	904-953-3930
Email	bunn.sabrina@mayo.edu
Status	Recruiting
Phase	N/A
Start date	February 19, 2020
Completion date	December 2025

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT03634007` - Gene Therapy for APOE4 Homozygote of Alzheimer's Disease	Phase 1/Phase 2
Completed	`NCT00867828` - Neptune Krill Oil (NKO™) in Early Stage Alzheimer's Disease (MNEMOSYNE)	Phase 4
Completed	`NCT03923517` - RHAPSODY-plus: Online Counseling for Family Caregivers of Patients With Young Onset Dementia	N/A
Terminated	`NCT01400542` - Sleep Apnea in Early to Mid-Stage Alzheimer's Disease	N/A
Recruiting	`NCT02875496` - Reference Database & Longitudinal Registry of the Normal and Pathological Aging Brain
Recruiting	`NCT03507257` - Longitudinal Early-onset Alzheimer's Disease Study Protocol